# US 2026/0166488 A1 · Optimizing conditions for antibody purification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0166488 A1
- Document ID: US20260166488A1
- Status: Published application
- Kind: A1
- Application number: 19/126,400
- Filed: 2022-11-03
- Published: 2026-06-18
- Earliest claimed: 2022-11-03
- Applicants: Bayer Healthcare LLC
- Inventors: Hendri TJANDRA; Florence RUSLY
- Web page: https://patentgrep.com/patent/US20260166488A1

## CPC

- B01D 61/20: Accessories; Auxiliary operations
- C07K 1/34: by filtration, ultrafiltration or reverse osmosis
- B01D 61/027: {Nanofiltration}
- B01D 61/145: {Ultrafiltration}
- B01D 61/18: Apparatus therefor
- B01D 63/04: comprising multiple hollow fibre assemblies
- B01D 69/08: Hollow fibre membranes (manufacture of hollow fibres D01D5/24, D01F1/08)
- C07K 1/22: Affinity chromatography or related techniques based upon selective absorption processes
- C07K 1/36: by a combination of two or more processes of different types
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 2317/73: Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

What is described herein relates to a method for optimizing purification conditions of a protein of interest comprising: a) prediction of filtration performance of a protein of interest based on the hydrophobicity of said protein of interest and/or b) filtration of a protein of interest wherein the protein of interest has an isoelectric point in the range of between 3.0 and 7.5 and the filtration is earned out at a pH above the isoelectric point.

## Claims

### Claim 1

A method for optimizing purification conditions of a protein of interest comprising
a) predicting filtration performance of a protein of interest based on the hydrophobicity of said protein of interest and/or
b) filtering a protein of interest wherein the protein of interest has an isoelectric point in the range of between 3.0 to 7.5 and the filtration is carried out at pH above the isoelectric point.

### Claim 2 (depends on 1)

The method according to claim 1 wherein the filtration according to part a) is a viral filtration.

### Claim 3 (depends on 1)

The method according to claim 1 wherein the filtering according to part b) is a viral filtration or a tangential flow filtration.

### Claim 4 (depends on 2)

The method according to claim 2, wherein the prediction of predicting viral filtration performance of a protein of interest based on the hydrophobicity of said protein of interest comprises
a.1) Determining the hydrophobicity of the protein of interest
a.2) Choosing a cellulose comprising hollow fiber viral filter membrane or a Polyvinylidene difluoride (PVDF) comprising hollow fiber viral filter membrane based on the hydrophobicity of the protein of interest.

### Claim 5 (depends on 2)

The method according to claim 2, wherein the determined hydrophobicity of the protein of interest is compared to a reference prior to choosing the viral filter type.

### Claim 6 (depends on 2)

The method according to claim 2, wherein the hydrophobicity of the protein of interest is determined using HIC-HPLC and/or RPLC and/or an algorithm for estimating the isoelectric point.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the protein of interest is expressed in a mammalian cell culture and is a monoclonal antibody.

### Claim 8 (depends on 2)

The method according to claim 2 wherein the filtration is carried out using a hollow fiber module.

### Claim 9 (depends on 8)

The method according to claim 8 wherein the hollow fiber module has a pore size of 20 nm.

### Claim 10 (depends on 3)

The method according to claim 3 wherein the filtration is carried out at a pH in the range of between 5.5-8.5.

### Claim 11 (depends on 3)

The method according to claim 3 wherein the isoelectric point of the protein of interest is determined via Imaged Capillary Isoelectric Focusing (iCIEF)

### Claim 12

Use of the hydrophobicity of a protein of interest to choose a viral filtration membrane.

### Claim 13

Filtration of a protein of interest wherein the protein of interest has an isoelectric point in the range of between 3.0 to 7.5 and the filtration is carried out at pH above the isoelectric point.
